Results
|
1.
|
Establishing an electronic health record-supported approach for outreach to and recruitment of persons at high risk of type 2 diabetes in clinical trials: The vitamin D and type 2 diabetes (D2d) study experience. MedStar authors:
Year: 2019
Citation: - Clinical Trials. 16(3):306-315, 2019 06.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Brodsky IG, Chadha C, Chatterjee R, D2d Research Group, Desouza C, LeBlanc ES, Ouellette MG, Phillips LS, Pittas AG, Sheehan PR, Staten MA, Vickery EM
|
|
2.
|
A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. MedStar authors:
Year: 2015
Citation: - Journal of Clinical Endocrinology & Metabolism. 100(5):1855-62, 2015 May.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Adam KP, Banerji M, Bray GA, Buchanan TA, Clement SC, Cobb JE, DeFronzo RA, Ferrannini E, Gall W, George T, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D
|
|
3.
|
Genetic risk of progression to type 2 diabetes and response to intensive lifestyle or metformin in prediabetic women with and without a history of gestational diabetes mellitus. MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(4):909-11, 2014 Apr.
Institution: - MedStar Washington Hospital Center
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Christophi CA, Dabelea D, Dagogo-Jack S, Diabetes Prevention Program Research Group, Florez JC, Franks PW, Jablonski KA, Kim C, Knowler WC, Ratner R, Sullivan SD
|
|
4.
|
|
|
5.
|
Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(9):2622-31, 2014 Sep.
All authors: - Diabetes Prevention Program Research Group, Goldberg RB, Hamman RF, Horton E, Kitabchi A, Larkin M, Mather KJ, Montez MG, Orchard TJ, Perreault L, Temprosa M, Thayer D
|
|
6.
|
Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. MedStar authors:
Year: 2013
Citation: - Arteriosclerosis, Thrombosis & Vascular Biology. 33(2):393-9, 2013 Feb.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Musi N, Ratner RE, Reaven PD, Saremi A, Schwenke DC, Stentz FB, Tripathy D
|